Takeda Pharmaceutical Co. Ltd. - Total Cashflows From Financing Activities

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Total-Cashflows-From-Financing-Activities" stands at -1.10 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of -0.012 Trillion JPY for the item "Total Cashflows From Financing Activities" represents an increase of 93.96 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of -0.012 Trillion JPY for the item "Total Cashflows From Financing Activities" represents an increase of 85.60 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of -1.10 Trillion JPY for the item "Total Cashflows From Financing Activities" represents an increase of 6.10 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.24 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is -1.24 Trillion Japanese Yens.
The 3 year change is -0.5261 Trillion Japanese Yens.
The 5 year change is -0.5992 Trillion Japanese Yens.
The 10 year change is -0.8041 Trillion Japanese Yens.

The Serie's long term average value is -0.0768 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is -1.02 Trillion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2021, to it's latest available value, on 09/30/2025, is +0.1188 Trillion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2019, to it's latest available value, on 09/30/2025, is -4.08 Trillion.